VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHCNational HealthCare Corporation
$206.54$3.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNHCFinancials

National HealthCare Corporation (NHC) Financials

30Y historyFree accessUpdated daily

Revenue growth has moderated significantly from a 28.7% peak in 2025Q2 to just 1.7% in 2026Q1, while gross margins compressed to 30.5% from the 38-39% range maintained throughout 2025.

NHC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue1.52B1.51B1.3B1.14B1.07B1.01B980.71M996.38M980.35M963.89M923.58M906.62M871.68M788.96M761M773.24M720.65M668.22M633.21M598.03M562.96M542.38M521.83M472.86M458.25M419.97M462.42M440.14M441.2M463.48M386.3M
Revenue Growth %10.89%16.38%13.7%6.26%6.27%3.08%-1.57%1.64%1.71%4.37%1.87%4.01%10.49%3.67%-1.58%7.3%7.85%5.53%5.88%6.23%3.79%3.94%10.36%3.19%9.12%-9.18%5.06%-0.24%-4.81%19.98%10.56%
Cost of Goods Sold957.05M485.77M810.93M712.34M686.17M666.06M609.31M592.83M582.72M572.04M548.01M532.74M510.25M453.56M426.93M428.67M400.27M558.85M538.51M502.09M157.66M150.16M149.56M129.72M127.05M111.72M119.59M121.35M163.5M140M123.3M
COGS % of Revenue-32.16%62.48%62.4%63.87%65.89%62.13%59.5%59.44%59.35%59.34%58.76%58.54%57.49%56.1%55.44%55.54%83.63%85.05%83.96%28.01%27.69%28.66%27.43%27.72%26.6%25.86%27.57%37.06%30.21%31.92%
Gross Profit567.07M1.02B487.01M429.2M388.11M344.88M371.41M403.55M397.63M391.85M375.57M373.89M361.43M335.4M334.07M344.57M320.38M109.37M94.7M95.94M405.29M392.22M372.27M343.15M331.21M308.25M342.83M318.8M277.7M323.48M263M
Gross Margin %37.21%67.84%37.52%37.6%36.13%34.11%37.87%40.5%40.56%40.65%40.66%41.24%41.46%42.51%43.9%44.56%44.46%16.37%14.95%16.04%71.99%72.31%71.34%72.57%72.28%73.4%74.14%72.43%62.94%69.79%68.08%
Gross Profit Growth %-110.42%13.47%10.59%12.54%-7.14%-7.97%1.49%1.47%4.33%0.45%3.45%7.76%0.4%-3.05%7.55%192.94%15.49%-1.3%-76.33%3.33%5.36%8.49%3.61%7.45%-10.09%7.54%14.8%-14.15%23%8.5%
Operating Expenses573.78M881.31M401.25M372.07M356.22M293.95M323.25M354.51M341.55M337.74M315.03M306.76M293.42M263.32M265.83M265.72M262.76M58.5M57.14M57.21M357.34M343M330.91M307.78M292.32M280.93M318.79M299.41M255.4M273.3M222.8M
OpEx % of Revenue-58.34%30.91%32.59%33.16%29.08%32.96%35.58%34.84%35.04%34.11%33.84%33.66%33.38%34.93%34.36%36.46%8.75%9.02%9.57%63.48%63.24%63.41%65.09%63.79%66.89%68.94%68.02%57.89%58.97%57.68%
Selling, General & Admin34.86M043.18M41.52M40.98M40.82M40.49M40.52M40.92M40.37M41.29M39.97M39.73M39.45M39.35M39.74M38.09M32.35M31.45M40.2M343.17M327.54M317.15M295.4M279.95M268.2M304.35M289.02M243.3M258.3M209.6M
SG&A % of Revenue--3.33%3.64%3.81%4.04%4.13%4.07%4.17%4.19%4.47%4.41%4.56%5%5.17%5.14%5.28%4.84%4.97%6.72%60.96%60.39%60.78%62.47%61.09%63.86%65.82%65.67%55.15%55.73%54.26%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses4M881.31M358.06M330.54M315.24M253.14M282.76M314M300.63M297.38M273.74M266.79M253.69M223.87M226.48M225.98M224.67M26.14M25.69M17.01M14.17M15.46M13.77M12.38M12.37M12.73M14.44M10.38M12.1M15M13.2M
Operating Income-6.71M143.45M85.76M57.13M31.9M50.92M48.16M49.04M56.08M54.11M60.54M67.13M68.01M72.08M68.24M78.85M57.63M50.87M37.55M38.73M47.95M49.22M41.35M35.37M38.89M27.32M24.04M19.39M22.3M50.18M40.2M
Operating Margin %-0.44%9.5%6.61%5%2.97%5.04%4.91%4.92%5.72%5.61%6.56%7.4%7.8%9.14%8.97%10.2%8%7.61%5.93%6.48%8.52%9.07%7.92%7.48%8.49%6.5%5.2%4.4%5.05%10.83%10.41%
Operating Income Growth %-67.27%50.1%79.13%-37.37%5.75%-1.8%-12.55%3.63%-10.62%-9.81%-1.3%-5.65%5.63%-13.46%36.83%13.28%35.47%-3.03%-19.23%-2.58%19.02%16.93%-9.05%42.35%13.64%23.99%-13.06%-55.56%24.82%5.79%
EBITDA38.85M188.37M127.75M99.17M72.39M91.6M90.17M91.46M97.97M96.76M99.56M104.24M102.39M100.63M98.03M107.75M84.77M76.3M62.37M55.73M60.66M63.37M53.79M46.57M50.03M39.18M38.48M29.77M34.4M65.18M53.4M
EBITDA Margin %2.55%12.47%9.84%8.69%6.74%9.06%9.19%9.18%9.99%10.04%10.78%11.5%11.75%12.75%12.88%13.94%11.76%11.42%9.85%9.32%10.78%11.68%10.31%9.85%10.92%9.33%8.32%6.76%7.8%14.06%13.82%
EBITDA Growth %-72.89%47.46%28.82%37%-20.97%1.58%-1.4%-6.65%1.25%-2.82%-4.48%1.8%1.76%2.65%-9.02%27.11%11.1%22.34%11.9%-8.12%-4.27%17.81%15.49%-6.92%27.69%1.82%29.25%-13.45%-47.22%22.05%0%
D&A (Non-Cash Add-back)45.56M44.92M41.98M42.03M40.49M40.67M42.02M42.42M41.89M42.65M39.02M37.11M34.38M28.55M29.79M28.9M27.14M25.43M24.82M17.01M12.71M14.15M12.44M11.21M11.15M11.87M14.44M10.38M12.1M15M13.2M
EBIT168.06M168.8M140.54M89.06M27.79M150.88M53.82M91.15M79.58M79.44M84.15M87.88M87.36M102.51M93.94M99.83M81.48M68.37M54.16M73.41M47.95M49.22M41.35M35.37M38.89M27.32M24.04M19.39M22.3M50.18M40.2M
Net Interest Income7.37M3.47M5.97M8.06M4.57M3.82M4.4M4.05M2.49M1.28M1.54M2.89M2.38M4.91M4.17M4.54M4.87M-716K-873K-1.17M00000000000
Interest Income9.91M9.84M10.1M8.38M5.13M4.67M5.79M7.19M7.18M6.17M5.48M5.49M4.55M5.24M4.62M4.98M5.38M00000000000000
Interest Expense2.54M6.37M4.13M324K563K845K1.4M3.13M4.7M4.89M3.94M2.61M2.17M331K455K443K513K716K873K1.17M00000000000
Other Income/Expense170.23M18.98M50.65M31.6M-4.67M99.11M4.27M38.98M18.81M20.44M19.66M18.15M17.18M30.09M25.25M20.53M23.34M16.78M15.73M33.51M6.33M-2.53M-1.3M-2.08M-11.44M-5.16M-6.88M-5.35M-32.4M-12.98M-40.2M
Pretax Income163.53M162.43M136.41M88.74M27.23M150.04M52.42M88.02M74.88M74.55M80.21M85.27M85.19M102.18M93.48M99.38M80.97M67.66M53.29M72.23M54.28M46.69M40.05M33.29M27.45M22.16M17.16M14.04M-10.1M37.2M0
Pretax Margin %10.73%10.75%10.51%7.77%2.53%14.84%5.35%8.83%7.64%7.73%8.68%9.41%9.77%12.95%12.28%12.85%11.24%10.12%8.42%12.08%9.64%8.61%7.68%7.04%5.99%5.28%3.71%3.19%-2.29%8.03%-
Income Tax37.11M39.83M34.32M23.45M7.25M10.95M10.43M20.04M16.18M18.87M29.67M32.13M31.82M37.56M34.18M34.39M28.27M27.61M16.92M26.79M17.54M18.05M16.08M13.34M11.01M8.96M6.94M5.65M-3.7M200K0
Effective Tax Rate %22.69%24.52%25.16%26.43%26.64%7.3%19.9%22.77%21.61%25.31%36.99%37.68%37.36%36.76%36.56%34.61%34.92%40.8%31.75%37.08%32.31%38.67%40.15%40.06%40.11%40.44%40.45%40.27%36.63%0.54%-
Net Income123.67M120.02M101.93M66.8M22.45M138.59M41.87M68.21M58.96M56.2M50.54M53.14M53.37M64.61M59.3M64.99M52.7M40.05M36.37M45.45M36.74M28.64M23.97M19.95M16.44M13.2M10.22M8.38M-6.4M37M29.3M
Net Margin %8.11%7.95%7.85%5.85%2.09%13.71%4.27%6.85%6.01%5.83%5.47%5.86%6.12%8.19%7.79%8.4%7.31%5.99%5.74%7.6%6.53%5.28%4.59%4.22%3.59%3.14%2.21%1.9%-1.45%7.98%7.58%
Net Income Growth %14.59%17.75%52.59%197.61%-83.8%230.99%-38.62%15.68%4.91%11.21%-4.9%-0.42%-17.4%8.96%-8.76%23.33%31.58%10.11%-19.97%23.7%28.3%19.45%20.15%21.38%24.52%29.18%21.89%230.98%-117.3%26.28%38.86%
Net Income (Continuing)126.42M122.61M102.09M65.29M19.98M139.09M41.99M67.98M58.7M55.68M50.54M53.14M53.37M64.61M59.3M64.99M52.7M40.05M36.37M45.45M36.74M28.64M23.97M19.95M16.44M13.2M10.22M8.38M-6.4M37M29.3M
Discontinued Operations0000000000000000000000000000000
Minority Interest5.67M5.74M3M1.73M3.24M5.46M3.08M476K1.18M694K-40.02M00000000001.19M874K812K750K000700K800K800K
EPS (Diluted)7.847.676.534.341.458.992.724.443.873.693.323.203.143.873.573.963.222.312.113.362.850.241.951.651.371.130.890.73-0.583.582.97
EPS Growth %13.73%17.46%50.46%199.31%-83.87%230.51%-38.74%14.73%4.88%11.14%3.75%1.91%-18.86%8.4%-9.85%22.98%39.39%9.48%-37.2%17.89%1087.5%-87.69%18.18%20.44%21.24%26.97%21.92%225.86%-116.2%20.54%28.02%
EPS (Basic)-7.766.624.361.469.032.744.473.873.703.343.343.244.053.654.093.222.312.163.472.990.342.051.721.431.170.890.73-0.584.173.48
Diluted Shares Outstanding15.77M15.65M15.6M15.38M15.45M15.42M15.37M15.36M15.24M15.22M15.21M14.49M14.22M16.7M16.6M16.41M13.68M13.58M13.13M12.99M12.89M12.79M12.29M12.06M11.97M11.68M11.47M11.42M11.12M10.34M9.87M
Basic Shares Outstanding15.54M15.47M15.39M15.31M15.41M15.35M15.31M15.27M15.22M15.19M15.13M13.89M13.82M13.83M13.85M13.77M13.67M13.56M12.83M12.56M12.29M12.24M11.69M11.61M11.51M11.27M11.45M11.42M11.12M8.87M8.42M
Dividend Payout Ratio-32.25%36.27%53.24%154.17%23.11%76.24%45.75%50.59%50.24%51.04%39.68%35.05%27.04%52.02%24.55%28.05%33.73%31.74%21.49%22.07%23.47%-------56.76%59.73%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowStable
Top Statement Risk

Labor cost inflation volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Shows Recent Deceleration

According to the latest quarterly filings, NHC's revenue growth has moderated significantly from the 28.7% peak observed in 2025Q2 to a modest 1.7% in 2026Q1, suggesting that the post-pandemic census recovery tailwinds may be normalizing as the company faces a more challenging year-over-year comparison base.

The sharp deceleration in top-line expansion indicates that the initial surge in patient volume is likely plateauing. Investors should monitor whether the company can sustain organic growth through its behavioral health initiatives or if the core skilled nursing segment is reaching a capacity ceiling in its primary Tennessee market.

Gross Margin Compression Warrants Scrutiny

As reported in recent financial statements, NHC experienced a notable contraction in gross margin to 30.5% in 2026Q1, a significant departure from the 38-39% range maintained throughout 2025, which may reflect rising clinical labor costs or shifts in the underlying payer mix toward lower-reimbursement Medicaid residents.

The sudden drop in gross profitability suggests that the company's ability to pass through cost increases to payers is currently lagging behind inflationary pressures. This margin volatility highlights the sensitivity of the business model to labor market tightness and the potential for regulatory reimbursement changes to impact facility-level profitability.

Operating Leverage Obscured by Volatility

Based on NHC's reported figures, the company's operating income turned negative in 2026Q1 at -$104.3M, marking a stark reversal from the consistent positive operating margins seen in previous quarters and indicating that fixed costs are currently outpacing the company's ability to generate sufficient operating leverage.

The inability to maintain positive operating income suggests that the company's cost structure is becoming increasingly rigid, potentially due to staffing mandates or non-recurring operational expenses. This trend warrants further investigation into whether the current operating loss is a temporary anomaly or a structural shift in the company's cost-to-revenue efficiency.

Net Income Decoupled From Operations

Data from recent SEC filings reveals that NHC reported a net income of $35.9M in 2026Q1 despite a significant operating loss, suggesting that non-operating items or investment gains are currently masking the underlying weakness in core healthcare service delivery and distorting the quality of reported earnings.

The reliance on non-operating income to bolster the bottom line raises concerns regarding the sustainability of current EPS levels. Analysts should strip out these volatile investment-related gains to assess the true operational health of the company's care facilities and determine if the core business remains fundamentally profitable.

NHC — Frequently Asked Questions

Quick answers to the most common questions about buying NHC stock.

What was National HealthCare Corporation's (NHC) revenue in 2025?

For fiscal year 2025, National HealthCare Corporation (NHC) reported total revenue of $1.51B. This represents a 291.0% increase compared to $386.3M in 1996.

Is National HealthCare Corporation (NHC) profitable?

National HealthCare Corporation (NHC) is profitable, generating $120.0M in net income for the fiscal year ending 2025 with a net profit margin of 7.9%.

What is National HealthCare Corporation's operating profit margin?

National HealthCare Corporation (NHC) reported an operating income of $143.4M, resulting in an operating profit margin of 9.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is National HealthCare Corporation's gross profit and gross margin?

National HealthCare Corporation (NHC) generated $1.02B in gross profit for the year, representing a gross profit margin of 67.8%. This demonstrates the company's core pricing power and production efficiency.